Cingulate (CINGW) Competitors $0.08 +0.01 (+8.41%) As of 01/17/2025 03:49 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsTrends CINGW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, and CELUWShould you be buying Cingulate stock or one of its competitors? The main competitors of Cingulate include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry. Cingulate vs. 180 Life Sciences 4D pharma Aesther Healthcare Acquisition Ainos Alvotech Atlantic Coastal Acquisition Corp. II Biofrontera biote BriaCell Therapeutics Celularity Cingulate (NASDAQ:CINGW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, media sentiment, analyst recommendations, risk, dividends, institutional ownership, earnings, community ranking and profitability. Is CINGW or ATNFW more profitable? Company Net Margins Return on Equity Return on Assets CingulateN/A N/A N/A 180 Life Sciences N/A N/A N/A Which has stronger valuation & earnings, CINGW or ATNFW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCingulateN/AN/AN/AN/AN/A180 Life SciencesN/AN/AN/AN/AN/A Does the media refer more to CINGW or ATNFW? In the previous week, 180 Life Sciences' average media sentiment score of 1.89 beat Cingulate's score of 1.87 indicating that 180 Life Sciences is being referred to more favorably in the news media. Company Overall Sentiment Cingulate Very Positive 180 Life Sciences Very Positive Does the MarketBeat Community favor CINGW or ATNFW? Cingulate and 180 Life Sciences both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformCingulateN/AN/A180 Life SciencesN/AN/A Summary180 Life Sciences beats Cingulate on 1 of the 1 factors compared between the two stocks. Get Cingulate News Delivered to You Automatically Sign up to receive the latest news and ratings for CINGW and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CINGW vs. The Competition Export to ExcelMetricCingulateBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$175.97M$5.36B$9.14BDividend YieldN/A3.64%5.13%4.04%P/E RatioN/A132.2189.4717.33Price / SalesN/A18,796.861,263.70136.49Price / CashN/A13.0143.7535.97Price / BookN/A9.535.324.80Net IncomeN/A-$20.89M$122.60M$224.91M7 Day PerformanceN/A-1.04%0.69%1.77%1 Month PerformanceN/A1.44%1.55%2.22%1 Year PerformanceN/A141.56%27.25%20.67% Cingulate Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CINGWCingulateN/A$0.08+8.4%N/A+432.7%$0.00N/A0.0020Positive NewsATNFW180 Life SciencesN/A$0.01+2.9%N/A+80.0%$0.00N/A0.007Positive NewsGap DownHigh Trading VolumeLBPSW4D pharmaN/AN/AN/AN/A$0.00$522,000.000.00N/AAEHAWAesther Healthcare AcquisitionN/A$0.03-2.7%N/A+48.3%$0.00N/A0.002Gap DownHigh Trading VolumeAIMDWAinosN/A$0.14+164.7%N/A+21.4%$0.00$40,633.000.0040News CoveragePositive NewsGap DownHigh Trading VolumeALVOWAlvotechN/A$3.30+6.1%N/A+21.3%$0.00$391.87M0.004Positive NewsGap UpACABWAtlantic Coastal Acquisition Corp. IIN/A$0.09+4.2%N/A+78.6%$0.00N/A0.004Gap UpBFRIWBiofronteraN/A$0.07+1.4%N/A+680.0%$0.00$35.36M0.0070Positive NewsBTMDWbioteN/A$0.45flatN/A-46.3%$0.00$193.06M0.00N/AGap DownBCTXWBriaCell TherapeuticsN/A$0.24-29.9%N/A-93.7%$0.00N/A0.008Short Interest ↑News CoveragePositive NewsGap DownCELUWCelularityN/A$0.02+1.0%N/A-32.3%$0.00$48.20M0.00220Positive News Related Companies and Tools Related Companies ATNFW Competitors LBPSW Competitors AEHAW Competitors AIMDW Competitors ALVOW Competitors ACABW Competitors BFRIW Competitors BTMDW Competitors BCTXW Competitors CELUW Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CINGW) was last updated on 1/18/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredStunning Trump Exec Order LeakedMost people have no clue this unassuming facility exists. Yet the minute Donald Trump takes office... ...Banyan Hill Publishing | SponsoredBitcoin to $200K?Newsweek recently asked several analysts whether they think Bitcoin will hit $200,000 by the end of 2025. T...Stansberry Research | SponsoredElon's "Final Move" Could Send This Stock SoaringWhenever Elon Musk starts a new venture... Early investors get the opportunity to become millionaires... ...Behind the Markets | SponsoredThe Biggest Money-Making Idea in My 43 Years in the Stock MarketBillionaires and top investors - including the late great Charlie Munger - and many more names you would recog...The Oxford Club | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cingulate Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cingulate With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
